Artículo

A novel digital cognitive biomarker for mild cognitive impairment and Alzheimer’s disease

Fernández, Gerardo AbelIcon ; Schumacher, Marcela SilvanaIcon ; Orozco, David; Sgrilli, Gustavo; Echeverria, Gustavo; Linares, Ramiro; Parra, Mario A.
Fecha de publicación: 12/2021
Editorial: Elsevier Science Inc.
Revista: Alzheimers & Dementia
ISSN: 1552-5260
Idioma: Inglés
Tipo de recurso: Artículo publicado
Clasificación temática:

Resumen

Recent evidence suggests that oculomotor behaviours linked to cognitive performance can be a biomarker of Alzheimer’s disease (AD). Short-Term Memory Binding (STMB) declines in patients with AD dementia and in those at risk of dementia. STMB relies on brain regions relevant to visual processing which are known to support oculomotor behaviours. Viewmind is proposed as a novel “cognitive digital biomarker” with the potential of revealing phenotypic features of AD in the pre-dementia stage of the pathology. Viewmind applies artificial intelligence to analyse eye movements and pupil responses during the performance of STMBT.
Palabras clave: ALZHEIMER , BIOMARKER , COGNITIVE BIOMARKER
 
Archivos asociados
Thumbnail
 
Tamaño: 317.9Kb
Formato: PDF
.
Licencia
info:eu-repo/semantics/openAccess Excepto donde se diga explícitamente, este item se publica bajo la siguiente descripción: Creative Commons Attribution-NonCommercial-ShareAlike 2.5 Unported (CC BY-NC-SA 2.5)
Identificadores
URI: http://hdl.handle.net/11336/197894
URL: https://onlinelibrary.wiley.com/doi/10.1002/alz.055018
DOI: http://dx.doi.org/10.1002/alz.055018
Colecciones
Articulos(IIIE)
Articulos de INST.DE INVEST.EN ING.ELECTRICA "A.DESAGES"
Citación
Fernández, Gerardo Abel; Schumacher, Marcela Silvana; Orozco, David; Sgrilli, Gustavo; Echeverria, Gustavo; et al.; A novel digital cognitive biomarker for mild cognitive impairment and Alzheimer’s disease; Elsevier Science Inc.; Alzheimers & Dementia; 17; S5; 12-2021; 1-2
Compartir
Altmétricas